Table 1.
Characteristics of COVID-19 patients.
| All subjects (n = 107) | |
|---|---|
| Male (%) | 68 |
| Age (years) | 55.76 ± 13.59 |
| Body mass index (Kg/m2) | 29.08 ± 5.60 |
| Comorbidities | |
| Hypertension (%) | 45.8 |
| Type 2 diabetes mellitus (%) | 38.3 |
| Obesity (%) | 34.6 |
| Dyslipidemia (%) | 10.3 |
| Ischemic heart disease (%) | 8.4 |
| Tabaquism (%) | 7.5 |
| Valvular disease (%) | 4.7 |
| Chronic kidney disease (%) | 3.7 |
| Hyperthyroidism (%) | 3.7 |
| Gout (%) | 1.9 |
| Systemic lupus erythematosus (%) | 1.9 |
| Antiphospholipid syndrome (%) | 1.9 |
| Pulmonary hypertension (%) | 0.9 |
| Initial symptoms | |
| Cough (%) | 62.5 |
| Fever (%) | 61.7 |
| Dyspnea (%) | 56.1 |
| Fatigue (%) | 38.3 |
| Myalgia (%) | 38.3 |
| Arthralgia (%) | 33.6 |
| Headache (%) | 24.3 |
| Odynophagia (%) | 20.6 |
| Diarrhea (%) | 17.8 |
| Diaphoresis (%) | 12.1 |
| Shaking chills (%) | 11.2 |
| Emesis (%) | 9.3 |
| Chest pain (%) | 9.3 |
| Anosmia (%) | 7.5 |
| Dysgeusia (%) | 5.6 |
| Abdominal pain (%) | 5.6 |
| Hyporexia (%) | 4.7 |
| Rhinorrhea (%) | 1.9 |
Data are shown as mean ± standard deviation or percentage.